Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2002 6
2003 8
2004 14
2005 5
2006 4
2007 9
2008 8
2009 5
2010 6
2011 11
2012 3
2013 5
2014 9
2015 9
2016 13
2017 16
2018 11
2019 18
2020 21
2021 20
Text availability
Article attribute
Article type
Publication date

Search Results

184 results
Results by year
Filters applied: . Clear all
Page 1
Old and New Biological Therapies for Psoriasis.
Rønholt K, Iversen L. Rønholt K, et al. Among authors: iversen l. Int J Mol Sci. 2017 Nov 1;18(11):2297. doi: 10.3390/ijms18112297. Int J Mol Sci. 2017. PMID: 29104241 Free PMC article. Review.
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Kim YH, et al. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Lancet Oncol. 2018. PMID: 30100375 Free article. Clinical Trial.
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL; UNCOVER-1 Study Group; UNCOVER-2 Study Group; UNCOVER-3 Study Group. Gordon KB, et al. N Engl J Med. 2016 Jul 28;375(4):345-56. doi: 10.1056/NEJMoa1512711. Epub 2016 Jun 8. N Engl J Med. 2016. PMID: 27299809 Free article. Clinical Trial.
MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas.
Gluud M, Willerslev-Olsen A, Gjerdrum LMR, Lindahl LM, Buus TB, Andersen MH, Bonefeld CM, Krejsgaard T, Litvinov IV, Iversen L, Becker JC, Persson JL, Koralov SB, Litman T, Geisler C, Woetmann A, Odum N. Gluud M, et al. Among authors: iversen l. Cancers (Basel). 2020 May 13;12(5):1229. doi: 10.3390/cancers12051229. Cancers (Basel). 2020. PMID: 32414221 Free PMC article. Review.
Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.
Lindahl LM, Willerslev-Olsen A, Gjerdrum LMR, Nielsen PR, Blümel E, Rittig AH, Celis P, Herpers B, Becker JC, Stausbøl-Grøn B, Wasik MA, Gluud M, Fredholm S, Buus TB, Johansen C, Nastasi C, Peiffer L, Kubat L, Bzorek M, Eriksen JO, Krejsgaard T, Bonefeld CM, Geisler C, Mustelin T, Langhoff E, Givskov M, Woetmann A, Kilian M, Litman T, Iversen L, Odum N. Lindahl LM, et al. Among authors: iversen l. Blood. 2019 Sep 26;134(13):1072-1083. doi: 10.1182/blood.2018888107. Epub 2019 Jul 22. Blood. 2019. PMID: 31331920 Free PMC article.
Clinical Goals and Barriers to Effective Psoriasis Care.
Strober BE, van der Walt JM, Armstrong AW, Bourcier M, Carvalho AVE, Chouela E, Cohen AD, de la Cruz C, Ellis CN, Finlay AY, Gottlieb AB, Gudjonsson JE, Iversen L, Kleyn CE, Leonardi CL, Lynde CW, Ryan C, Theng CT, Valenzuela F, Vender R, Wu JJ, Young HS, Kimball AB. Strober BE, et al. Among authors: iversen l. Dermatol Ther (Heidelb). 2019 Mar;9(1):5-18. doi: 10.1007/s13555-018-0279-5. Epub 2018 Dec 21. Dermatol Ther (Heidelb). 2019. PMID: 30578464 Free PMC article.
Time is running out for sand.
Bendixen M, Best J, Hackney C, Iversen LL. Bendixen M, et al. Among authors: iversen ll. Nature. 2019 Jul;571(7763):29-31. doi: 10.1038/d41586-019-02042-4. Nature. 2019. PMID: 31267054 No abstract available.
184 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page